Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations.
Ann Oncol
; 28(11): 2793-2798, 2017 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-28945881
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nuclear Proteins
/
Leukemia, Myeloid, Acute
/
Biomarkers, Tumor
/
Hematopoietic Stem Cell Transplantation
/
CCAAT-Enhancer-Binding Proteins
/
Fms-Like Tyrosine Kinase 3
/
Mutation
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Year:
2017
Document type:
Article